Rating : 10/10 (⭐⭐⭐⭐⭐)
🔹Prof. Dr. med. Jürgen Gschwend is an esteemed figure in urology, boasting an extensive academic background that includes studies at Ludwig Maximilian University of Munich and the University of Ulm, Germany.
🔹He obtained his degree in Medicine in 1981, following a successful thesis defense. His career trajectory included an internship at the University Hospital Ulm, Germany, and a significant period at the Memorial Sloan Kettering Cancer Center in the USA from 1995 to 1996, supported by a scholarship from the German Research Foundation.
🔹Notably, in 1998, he completed a habilitation on "Induction of Apoptosis in Prostate Cancer." Since 2006, Prof. Gschwend has served as a Professor and Head of the Department of Adult and Pediatric Urology at University Hospital Rechts der Isar Munich.
🔹His research spans surgical, clinical, and experimental urology, particularly focusing on the molecular biology of bladder and prostate cancer, exploring micrometastases and signaling pathways.
🔹Prof. Gschwend holds key positions in professional societies, including being the Official Representative of the Working Group on Urologic Oncology in the German Cancer Society, a Member of the Board of Directors and Coordinator in the German Society of Urology, and Deputy Chairman of the Comprehensive Cancer Center Munich.
🔹His contributions have been recognized with numerous awards, such as the Award of the Faculty of Medicine and the Medical Association of the Technical University of Munich in 2008, the Maximilian Nitze Prize from the German Society of Urology, and the Merkle Research Prize from the University of Ulm in 2000.
🔹Prof. Dr. med. Jürgen Gschwend stands as a distinguished figure in urology, contributing significantly to its advancements through his research, leadership, and notable accolades within the field.
🔹Prof. Jürgen Gschwend studied medicine at LMU Munich and graduated in 1988.
🔹He then completed his clinical training at the University Hospital Ulm.
🔹In 1995, he received a DFG scholarship to conduct research at the Memorial Sloan-Kettering Cancer Center in New York.
🔹In 1998, he earned his habilitation in the field of apoptosis induction in prostate cancer.
🔹Since 2006, Prof. Gschwend has served as the Director of the Department of Urology at the Klinikum rechts der Isar at the Technical University (TU) Munich.
🔹He is also a full professor of Urology at TU Munich and holds the Chair of
Urology.
🔹Operative Uro-Oncology
🔹Medical Therapy for Urological Tumor Diseases
